Lipid-lowering and anti-aggregant Allicor activity in patients with moderate hypercholesterolemia
Aim. To assess long-term (6 months) Allicor therapy effects on lipid profile, lipid peroxidation (LP), and functional platelet (PL) activity in patients with moderate hypercholesterolemia (HCH). Material and methods. The study included 56 patients with clinically manifested atherosclerosis and 56 pa...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2007-10-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1356 |